Krsnaa Diagnostics Ltd Analyst Rating
based on 3 analysts
100.00%
Buy
0.00%
Hold
0.00%
Sell
Based on 3 analysts offering long term price targets for Krsnaa Diagnostics Ltd. An average target of ₹983.67
Source: S&P Global Market Intelligence
Krsnaa Diagnostics Ltd Share analysis
Krsnaa Diagnostics Ltd price forecast by 3 analysts
Upside of5.26%
High
₹1084
Target
₹983.67
Low
₹841
Krsnaa Diagnostics Ltd target price ₹983.67, a slight upside of 5.26% compared to current price of ₹934.7. According to 3 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
Krsnaa Diagnostics Ltd revenue growth forecast
Expected growth rate Q1, FY2026:65.05%
Forecast
Actual
Including amortisation and stock based compensations
Krsnaa Diagnostics Ltd EPS growth forecast
EPS estimate Q1, FY2026:110.40%
Forecast
Actual
Source: S&P Global Market Intelligence
Krsnaa Diagnostics Ltd Performance
Day's Low
Day's High
₹915.25₹949.952 Week's Low
52 Week's High
₹528.05₹973.45
| Returns % | |
| 1 Month Return | + 12.31 % |
| 3 Month Return | + 29.49 % |
| 1 Year Return | + 48.13 % |
| Market Stats | |
| Previous Close | ₹934.50 |
| Open | ₹940.00 |
| Volume | 1.05L |
| Upper Circuit | - |
| Lower Circuit | - |
| Market Cap | ₹3,017.48Cr |
Krsnaa Diagnostics Ltd Key Statistics
| P/E Ratio | 43.44 |
| PEG Ratio | 13.92 |
| Market Cap | ₹3,017.48 Cr |
| P/B Ratio | 2.44 |
| EPS | 17.6 |
| Dividend Yield | 0.41 |
| Sector | Healthcare |
| ROE | 7.52 |
Krsnaa Diagnostics Ltd Peer Comparison
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
|---|---|---|---|---|---|---|
| BUY | ₹3,017.48 Cr | -1.06% | 0.59 | ₹56 Cr | ₹619 Cr | |
| HOLD | ₹25,420.21 Cr | 18.47% | 0.55 | ₹362 Cr | ₹2,226 Cr | |
| NA | ₹39.83 Cr | 32.5% | 1.33 | ₹2 Cr | ₹10 Cr | |
| NA | ₹37.59 Cr | -4.97% | 0.54 | NA | NA | |
| NA | ₹133.28 Cr | -1.48% | 0.82 | NA | NA |
Krsnaa Diagnostics Ltd Mutual Fund Holdings
About Krsnaa Diagnostics Ltd
Krsnaa Diagnostics Ltd offers a wide range of diagnostic tests and services such as complete blood count, urine analysis, thyroid tests, diabetes tests, HIV tests and many more. The company also provides genetic testing services such as genetic counselling and carrier screening. Krsnaa Diagnostics Ltd's top products include advanced diagnostic equipment and reagents, laboratory information systems and laboratory automation systems.
Share Price: ₹934.70 per share as on 21 Nov, 2024 04:01 PM
Market Capitalisation: ₹3,017.48Cr as of today
Revenue: ₹186.34Cr as on September 2024 (Q3 24)
Net Profit: ₹19.60Cr as on September 2024 (Q3 24)
Listing date: 16 Aug, 2021
Chairperson Name: Rajendra Mutha
| Organisation | Krsnaa Diagnostics Ltd |
| Headquarters | |
| Industry | Healthcare |
| E-voting on shares | Click here to vote |
Key events for Krsnaa Diagnostics Ltd
Krsnaa Diagnostics Reports Strong Q2 Performance - 28 Oct, 2024
Krsnaa Diagnostics reported a solid Q2 with net sales of ₹186.34 crore, a nearly 6% surge in shares, and significant profit growth, showcasing strong operational efficiency.
Krsnaa Diagnostics Set to Report Q2 Results - 25 Oct, 2024
Krsnaa Diagnostics is one of the 148 companies scheduled to announce their Q2 earnings today, indicating potential market activity and investor interest.
Krsnaa Diagnostics Secures Major Agreements in Ranchi - 11 Oct, 2024
Krsnaa Diagnostics has secured significant agreements with RINPAS and Sadar Hospital to provide radiology and pathology services, boosting its market presence. The stock reached a 52-week high amid positive developments.
Krsnaa Diagnostics Expands Services in Ranchi - 10 Oct, 2024
Krsnaa Diagnostics has secured agreements to expand its radiology and pathology services in Ranchi through partnerships with RINPAS and Sadar Hospital, enhancing its presence in the PPP diagnostics segment.
Krsnaa Diagnostics Targets Strong Growth in FY25 - 08 Oct, 2024
Krsnaa Diagnostics aims for a top-line growth of 25-30% in FY25, with an EBITDA margin of 25-26%. The company is expanding its market through strategic collaborations and a B2C segment.
Krsnaa Diagnostics Partners for Expansion and Growth - 01 Oct, 2024
Krsnaa Diagnostics Ltd partners with Boston Ivy Healthcare and United Imaging for advanced diagnostic equipment, planning over ₹300 crore investment for 30 new imaging centers. Revenue rose 23% year-on-year, with net profit increasing by 20%. The company aims for 25% growth and a 30% margin in the future.
Insights on Krsnaa Diagnostics Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTFII Holding Up
Foreign Institutions have increased holdings from 3.33% to 3.63% in Sep 2024 quarter
- POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 8 quarters, 122.64 Cr → 190.93 Cr (in ₹), with an average increase of 6.1% per quarter
- POSITIVE IMPACT
Price Rise
In the last 1 month, KRSNAA stock has moved up by 12.3%
- POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 2 quarters, 17.92 Cr → 19.6 Cr (in ₹), with an average increase of 8.6% per quarter
NO EFFECTAgainst Peers
In the last 1 year, Fortis Healthcare Ltd has given 76.6% return, outperforming this stock by 28.5%
- NO EFFECT
Promoter Holding Unchanged
Promoters holdings remained unchanged at 27.17% of holdings in Sep 2024 quarter
- NO EFFECT
Against Peers
In the last 3 years, Max Healthcare Institute Ltd has given 191.3% return, outperforming this stock by 142.9%
NEGATIVE IMPACTMF Holding Down
Mutual Funds have decreased holdings from 11.91% to 11.56% in Sep 2024 quarter
- NEGATIVE IMPACT
Retail Holding Down
Retail Investor have decreased holdings from 54.24% to 53.34% in Sep 2024 quarter
Krsnaa Diagnostics Ltd Financials
Index Inclusions
Krsnaa Diagnostics Ltd Shareholding Pattern
| Investors | Holdings % | FY Quarter | 3M change |
|---|---|---|---|
| Promoter Holdings | 27.17% | 0.00 | |
| Foreign Institutions | 3.63% | 9.05 | |
| Mutual Funds | 11.56% | ||
| Retail Investors | 53.34% | ||
| Others | 4.3% | 28.30 |
Krsnaa Diagnostics Ltd Key Indicators
Krsnaa Diagnostics Ltd Valuation
Krsnaa Diagnostics Ltd in the last 5 years
Lowest (15.18x)
March 31, 2022
Today (43.44x)
November 19, 2024
Industry (96.41x)
November 19, 2024
Highest (46.36x)
September 20, 2024
Krsnaa Diagnostics Ltd Earnings and Dividends
Krsnaa Diagnostics Ltd Earnings Results
Krsnaa Diagnostics Ltd’s net profit jumped 86.67% since last year same period to ₹19.60Cr in the Q2 2024-2025. On a quarterly growth basis, Krsnaa Diagnostics Ltd has generated 9.37% jump in its net profits since last 3-months.
Read More about Earnings ResultsKrsnaa Diagnostics Ltd Dividends May,2024
In the quarter ending March 2024, Krsnaa Diagnostics Ltd has declared dividend of ₹2.50 - translating a dividend yield of 0.56%.
Read More about Dividends
Krsnaa Diagnostics Ltd Technicals Summary
Bearish
Neutral
Bullish
Krsnaa Diagnostics Ltd is currently in a Bullish trading position according to technical analysis indicators.
FAQs on Krsnaa Diagnostics Ltd
- Get a PAN card.
- Open a Demat account.
- Open a Trading account.
- Link your Demat account to your Trading account.
- Fund your Trading account.
- Place an order to buy Krsnaa Diagnostics Ltd shares.
Krsnaa Diagnostics Ltd (KRSNAA) share price today is ₹934.7
Krsnaa Diagnostics Ltd is listed on NSE
Krsnaa Diagnostics Ltd is listed on BSE
- Today’s highest price of Krsnaa Diagnostics Ltd is ₹949.9.
- Today’s lowest price of Krsnaa Diagnostics Ltd is ₹915.25.
PE Ratio of Krsnaa Diagnostics Ltd is 43.44
PE ratio = Krsnaa Diagnostics Ltd Market price per share / Krsnaa Diagnostics Ltd Earnings per share
Today’s traded volume of Krsnaa Diagnostics Ltd(KRSNAA) is 1.05L.
Today’s market capitalisation of Krsnaa Diagnostics Ltd(KRSNAA) is ₹3017.48Cr.
| Krsnaa Diagnostics Ltd(KRSNAA | Price |
|---|---|
52 Week High | ₹973.45 |
52 Week Low | ₹528.05 |
Krsnaa Diagnostics Ltd(KRSNAA) share price is ₹934.7. It is down -3.98% from its 52 Week High price of ₹973.45
Krsnaa Diagnostics Ltd(KRSNAA) share price is ₹934.7. It is up 77.01% from its 52 Week Low price of ₹528.05
| Krsnaa Diagnostics Ltd(KRSNAA | Returns |
|---|---|
1 Day Returns | 0.2% |
1 Month Returns | 12.31% |
3 Month Returns | 29.49% |
1 Year Returns | 48.13% |